BIOD

Biodel Inc. News Headlines

$1.34
*  
unch
unch
Get BIOD Alerts
*Delayed - data as of Mar. 4, 2015  -  Find a broker to begin trading BIOD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    BIOD After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Pacira Q4 & 2014 Revenues to Come In Line with Estimates - Analyst Blog
1/9/2015 4:20:00 PM - Zacks.com


Valeant Up on Better-than-Expected 2015 Outlook, Eyes Deals - Analyst Blog
1/9/2015 5:50:00 AM - Investopedia


Infinity Pharmaceuticals Falls on Duvelisib Study Results - Analyst Blog
1/9/2015 5:00:00 AM - Investopedia


Pacira Q4 & 2014 Revenues to Come In Line with Estimates - Analyst Blog
1/9/2015 4:20:00 AM - Investopedia


Alexion Reports Disappointing Phase II Data on Soliris - Analyst Blog
1/8/2015 4:45:00 PM - Zacks.com


Biodel Posts Positive Preliminary Data on its Diabetes Drug - Analyst Blog
1/8/2015 4:00:00 PM - Zacks.com


BioLineRx Finishes Dose-Escalation in Phase I BL-8040 Study - Analyst Blog
1/8/2015 1:40:00 PM - Investopedia


BioLineRx Finishes Dose-Escalation in Phase I BL-8040 Study - Analyst Blog
1/8/2015 1:40:00 PM - Zacks.com


Health Care Sector Update for 01/08/2015: BIOD,BIND,PODD
1/8/2015 12:54:32 PM - MT Newswires


Alexion Reports Disappointing Phase II Data on Soliris - Analyst Blog
1/8/2015 4:45:00 AM - Investopedia


Biodel Posts Positive Preliminary Data on its Diabetes Drug - Analyst Blog
1/8/2015 4:00:00 AM - Investopedia


Biodel Announces Positive Preliminary Results From Study 3-151
1/7/2015 9:09:00 PM - RTT News


NeuroDerm Ltd. (NDRM) in Focus: Stock Surges 13.2% - Tale of the Tape
1/7/2015 9:11:00 AM - Zacks.com


RedHill Announces Milestones & Regulatory Events for 2015 - Analyst Blog
1/6/2015 4:00:00 PM - Zacks.com


Foamix Pharmaceuticals (FOMX) Surges: Stock Moves 12.1% Higher - Tale of the Tape
1/6/2015 9:11:00 AM - Zacks.com


RedHill Announces Milestones & Regulatory Events for 2015 - Analyst Blog
1/6/2015 4:00:00 AM - Investopedia


Cempra Reports Positive Results on Antibiotic Solithromycin - Analyst Blog
1/5/2015 5:25:00 PM - Zacks.com


Cempra Reports Positive Results on Antibiotic Solithromycin - Analyst Blog
1/5/2015 5:25:00 AM - Investopedia


RedHill's Bekinda Accepted for Review in the EU, Shares Up - Analyst Blog
1/2/2015 4:40:00 PM - Zacks.com


RedHill's Bekinda Accepted for Review in the EU, Shares Up - Analyst Blog
1/2/2015 4:40:00 AM - Investopedia


RedHill's Bekinda Accepted for Review in the EU, Shares Up - Analyst Blog
1/2/2015 4:40:00 AM - Investopedia


ARIAD & Angelini Team Up to Commercialize Iclusig in Europe - Analyst Blog
12/31/2014 2:35:00 PM - Investopedia


ARIAD & Angelini Team Up to Commercialize Iclusig in Europe - Analyst Blog
12/31/2014 2:35:00 PM - Zacks.com


Spectrum/Ligand Pharma Seek FDA Nod for CE-Melphalan - Analyst Blog
12/29/2014 5:00:00 PM - Zacks.com


Cerus Corporation Reports Phase II Red Blood Cells Data - Analyst Blog
12/29/2014 4:00:00 PM - Zacks.com